Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Helmar Lehmann, University of Cologne
ClinicalTrials.gov Identifier:
NCT01655394
First received: July 30, 2012
Last updated: December 11, 2014
Last verified: December 2014

July 30, 2012
December 11, 2014
October 2012
December 2014   (final data collection date for primary outcome measure)
Clinical Improvement [ Time Frame: 6 Months ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01655394 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

Serum

Probability Sample

patients with immune neuropathies

  • Guillain-Barre Syndrome
  • CIDP
  • Multifocal Motor Neuropathy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
50
June 2016
December 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • immune neuropathy
  • age above 18 y
  • IVIg treatment

exclusion:

  • no IVIg treatment
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01655394
01607831337
No
Helmar Lehmann, University of Cologne
University of Cologne
Not Provided
Principal Investigator: Helmar C. Lehmann, PD Dr. med. PI
University of Cologne
December 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP